Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/05/2003US20030104562 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104561 For stimulating tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104559 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104558 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104557 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; cancer diagnosis
06/05/2003US20030104556 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104555 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104554 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypetide; cancer diagnosis
06/05/2003US20030104553 Isolation of human chorionic gonadotropin protein through ion exchange and size exclusion chromatography
06/05/2003US20030104552 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation/ of chondrocytes, by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104551 For stimulating release of tumor necrosis factor and /or proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
06/05/2003US20030104550 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104549 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104548 For stimulationg release of tumor necrosis factor and/or cellular proliferation/differeniation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104547 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104546 Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swollenins
06/05/2003US20030104545 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104544 For stimulating release of tumor necrosis factor and or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104543 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104542 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104541 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104540 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentialtion of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104539 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104538 For stimulating release of tumor necrosis factor, and or cellular proliferation/differentialtion chondrocytes by contacting blood with polypeptides; cancer diagnosis
06/05/2003US20030104536 Vesicle trafficking proteins; macrophage inflammatory proteins; cytokines induced neutrophil chemoattractant
06/05/2003US20030104535 Adheson variants
06/05/2003US20030104534 DNA encoding orphan SNORF42 receptor
06/05/2003US20030104532 Neuroprotectants; angoigenesis inhibitors; transcription factors
06/05/2003US20030104531 DNA molecules encoding human nuclear receptor protein nNR7-1
06/05/2003US20030104530 Inhibiting competetive binding; maintenance of organelle equilibrium; drug resistance
06/05/2003US20030104529 Hybridization probes for herpes virus thymidine kinases; polymorphisms; chromosome and genetic mapping; antisense agents
06/05/2003US20030104528 Lymphocytes; transcription factors; interferons
06/05/2003US20030104526 Rational design of polypeptides containing non-modulatory zinc finger, i.e, its sequence specificity depends on its location in multi-finger protein
06/05/2003US20030104524 Metal binding proteins, recombinant host cells and methods
06/05/2003US20030104523 Process for high throughput screening of CpG-based immuno-agonist/antagonist
06/05/2003US20030104521 Disease associated gene
06/05/2003US20030104519 Xenobiotic compound modulated expression systems and uses therefor
06/05/2003US20030104518 FIL-1 theta DNAs and polypeptides
06/05/2003US20030104516 Protein kinase npk-110
06/05/2003US20030104504 Chemical modification
06/05/2003US20030104502 Expression vector for use in screening antibiotics for prevention of neisseria infections
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104497 Recombinant scFV antibodies specific to Eimeria spp. responsible for coccidiosis
06/05/2003US20030104496 Novel motor protein of P. falciparum and methods for its use
06/05/2003US20030104495 Kinase for use as sex preferential contraceptive
06/05/2003US20030104490 High throughput assay for use in treatment and monitoring of diabetes
06/05/2003US20030104488 Amyloid protein for use in treatment of nervous system disorders
06/05/2003US20030104485 Antibodies specific for osteoprotegerin binding proteins and method of use
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104477 Immunoglobulin library for use in diagnosis, prevention and treatment of autoimmune diseases
06/05/2003US20030104472 Protein for use in treatment of cancer and sexual disorders
06/05/2003US20030104469 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of gastrointestinal, cancer and kidney disorders
06/05/2003US20030104450 Novel regulator of g protein signalling
06/05/2003US20030104447 Nucleotide sequences coding polypeptide for use in treatment and detection of respiratory, skin and infectious disorders
06/05/2003US20030104443 Nucleotide sequences coding polypeptide for use in treatment, diagnosis, and prevention of cancer
06/05/2003US20030104441 Method of concentrating and recovering a viral enzyme activity from biological samples
06/05/2003US20030104435 Nucleotide sequences coding receptor protein for use in treatment of nervous system, rheumatic, psychological, inflammatory, skin and infectious disorders
06/05/2003US20030104429 Nucleotide sequences coding polypeptide for use in the treatment of brain and nervous system disorders
06/05/2003US20030104424 Detection of allelic variation in mammals which is associated with amplified immunities against infection
06/05/2003US20030104419 Method of classifying a thyroid carcinoma using differential gene expression
06/05/2003US20030104418 Diagnostic markers for breast cancer
06/05/2003US20030104417 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
06/05/2003US20030104414 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of obesity and diabetes
06/05/2003US20030104413 Novel Nucleic acids and polypeptides
06/05/2003US20030104412 Kit for use in diagnosis and detection of tumors
06/05/2003US20030104407 Methods for diagnosis and treatment of MDK1 signal transduction disorders
06/05/2003US20030104406 Modified and stabilized GDF propeptides and uses thereof
06/05/2003US20030104403 Nucleotide sequence coding transferase enzyme for use in treatment cancer
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030104399 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of body weight and aging disorders
06/05/2003US20030104385 Enzymatic polypeptide for use in the diagnosis and treatment of psychological disorders
06/05/2003US20030104384 Trangenic cell library for monitoring phenotypic adjustments associated with gene transfer
06/05/2003US20030104381 Nucleotide sequences coding polypeptide for use in treatment of heart, cancer and skin disorders
06/05/2003US20030104377 Tenascin-C nucleic acid ligands
06/05/2003US20030104375 Light-driven energy generation using proteorhodopsin
06/05/2003US20030104374 Gene encoding MNR2 and uses thereof
06/05/2003US20030104366 Polypeptides for use in the diagnosis and prevention of tumors; antiproliferative agents
06/05/2003US20030104365 Polypeptide for use in the diagnosis and treatment of alzheimer's disease
06/05/2003US20030104364 Reagents and methods useful for detecting diseases of the breast
06/05/2003US20030104362 Cell-cycle regulatory proteins from human pathogens, and uses related thereto
06/05/2003US20030104356 Compounds and methods for treating and screening viral reactivation
06/05/2003US20030104355 Adapter-directed display systems
06/05/2003US20030104351 FIZZ1 for metabolism regulation
06/05/2003US20030104064 Biodegradable, resistant to salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030104009 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
06/05/2003US20030104008 In vivo and in vitro expression vectors comprising and expressing at least one polynucleotide of West Nile fever virus, as well as immunogenic compositions and vaccines against West Nile fever
06/05/2003US20030104003 Novel surface protein of the malaria parasite plasmodium falciparum
06/05/2003US20030104002 Antigenic iron repressible proteins from N. meningitidis related to the hemolysin family of toxins
06/05/2003US20030104000 Peptide encoded by gene identified herein as pho2-2, obtainable from Group B Streptococcus, or a homologue or a functional fragment thereof; neonatal infections, urinary tract infections
06/05/2003US20030103999 Novel therapeutic compositions for treating infection by Lawsonia spp.
06/05/2003US20030103998 Treatment of HIV and other viral infections using combinatorial therapy
06/05/2003US20030103997 Can be used to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection
06/05/2003US20030103993 HLA-DR2 binding peptides
06/05/2003US20030103992 Cadherin-like asymmetry proteins, in particular, polynucleotides, polypeptides, fusion proteins, and antibodies; for modulating immune response
06/05/2003US20030103991 For serodiagnosing ehrlichiosis in mammals, particularly in members of the Canidae family and in humans
06/05/2003US20030103990 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
06/05/2003US20030103986 TACI-immunoglobulin fusion proteins
06/05/2003US20030103984 Fusion proteins of biologically active peptides and antibodies
1 ... 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 ... 2916